Search

Detecting a protein in a blood sample could help doctors make treatment decisions for prostate cancer patients.

… Friday, June 29, 2018 Summary A study shows that a blood test that detects a protein called AR-V7 in circulating tumor cells accurately predicts how well certain people with prostate cancer will respond to drugs called AR inhibitors. Doctors can use this test to make decisions about whether these patients

Performing minimally invasive robotic cystectomy and bladder reconstruction in one operation provides a viable alternative to open surgery with less blood loss, decreased pain, diminished wound morbidity, and the potential for faster return of bowel function.

… Friday, November 10, 2017 Performing minimally invasive robotic cystectomy and bladder reconstruction in one operation provides a viable alternative, while maintaining the oncologic standards of the open approach. Some of the benefits appear to be less blood loss, decreased pain, and potentially less

Learn about a new CAR T cell treatment option for multiple myeloma that could work after other therapies have failed.

… Wednesday, September 28, 2022 Multiple myeloma Multiple myeloma , a rare blood cancer, now has many treatment options.   A new CAR T cell therapy CAR T cell therapy targeting an antigen called GPRC5D appears to be safe and effective. For people with multiple myeloma, prognosis has improved considerably

QUEENS, NY, January 17, 2007 - The Queens Library HealthLink initiative was developed to place libraries at the center of an innovative new effort designed to help medically underserved communities throughout Queens access free cancer information, early detection screenings, cancer treatment resources, and other life-saving services.

… Wednesday, January 17, 2007 Five-Year Initiative Will Help Increase Access to Cancer Screenings and Care Among Medically Underserved Communities In Queens In 2007, the American Cancer Society estimates that in the borough of Queens, 182 people will be diagnosed with cancer each week and 68 people will

A new study by thoracic surgeons and pathologists at Memorial Sloan Kettering Cancer Center shows that a specific pattern found in the tumor pathology of some lung cancer patients is a strong predictor of recurrence.

… Wednesday, August 7, 2013 A new study by thoracic surgeons and pathologists at Memorial Sloan Kettering Cancer Center shows that a specific pattern found in the tumor pathology of some lung cancer patients is a strong predictor of recurrence. Knowing that this feature exists in a tumor’s pathology could

New research looks at how a series of mutations in normal blood cells can lead to them becoming cancerous and how these mutations accumulate as cancer progresses.

… Wednesday, October 28, 2020 Summary The biggest study ever to examine the genetic causes of leukemia at the level of individual cells reveals how a series of mutations in normal blood cells can lead to them eventually becoming cancerous. When Memorial Sloan Kettering postdoctoral fellows Linde Miles

Kieran Healy was feeling worse by the day. A new father at 43 years old, he was bone-tired and losing weight. He had night sweats and a strange lump in his belly. His local hospital in Manhattan ordered an ultrasound and a CT (computed tomography) scan — but they were scheduled over a month away.

… Monday, June 5, 2023 Kieran Healy was feeling worse by the day. A new father at 43 years old, he was bone-tired and losing weight. He had night sweats and a strange lump in his belly. His local hospital in Manhattan ordered an ultrasound and a CT (computed tomography) scan — but they were scheduled over

Data from a recent study on women enrolled in Memorial Sloan Kettering Cancer Center’s high-risk breast cancer surveillance program highlights that a “substantial number” would benefit from interventions to mitigate modifiable risk.

… Wednesday, August 23, 2017 Data from a recent study on women enrolled in Memorial Sloan Kettering Cancer Center’s high-risk breast cancer surveillance program highlights that a “substantial number” would benefit from interventions to further reduce risk, including education on modifiable lifestyle factors

Researchers at Memorial Sloan Kettering Cancer Center (MSK), have published the first systemic review of the association between industry payments and physician prescribing in order to determine whether evidence is sufficient to conclude that payments cause physicians to change their prescribing practices across a broad range of  medical specialties and drug types.

… Monday, November 23, 2020 Researchers at Memorial Sloan Kettering Cancer Center (MSK), led by Aaron Mitchell, MD, MPH, a medical oncologist and health services researcher in the  Department of Epidemiology and Biostatistics , have published the first systemic review of the association between industry

Wondering how cryo-electron microscopy will impact medicine? Hear it from the source.

… Friday, September 9, 2016 Summary Memorial Sloan Kettering recently acquired a powerful new microscope that promises to greatly enhance scientists’ ability to understand the structure and function of biological molecules — including those that malfunction in cancer. In biology, structure and function